X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare GSK Consumer with Dabur - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK CONSUMER vs DABUR - Comparison Results

GSK CONSUMER    Change

GSK Consumer dominates the Rs 26 bn Indian malted beverage market with a significant 70% share (in volume terms). Its white beverage brand 'Horlicks' pioneered the broadening of the malted beverage market in India. Horlicks alone, as a white beverage... More

DABUR 
   Change

With over 125 years of existence, Dabur India is the fourth largest FMCG company in India. The company has a distinct positioning on the traditional Ayurvedic healthcare system having presence in personal care, health care and food. Domestic consumer... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GSK CONSUMER DABUR GSK CONSUMER/
DABUR
 
P/E (TTM) x 37.0 49.4 74.9% View Chart
P/BV x 9.0 12.5 72.6% View Chart
Dividend Yield % 1.0 1.9 54.0%  

Financials

 GSK CONSUMER   DABUR
EQUITY SHARE DATA
    GSK CONSUMER
Mar-18
DABUR
Mar-18
GSK CONSUMER/
DABUR
5-Yr Chart
Click to enlarge
High Rs6,793368 1,845.8%   
Low Rs4,919265 1,855.3%   
Sales per share (Unadj.) Rs1,026.343.8 2,341.1%  
Earnings per share (Unadj.) Rs166.57.7 2,159.5%  
Cash flow per share (Unadj.) Rs181.88.6 2,106.5%  
Dividends per share (Unadj.) Rs75.007.50 1,000.0%  
Dividend yield (eoy) %1.32.4 54.1%  
Book value per share (Unadj.) Rs828.632.4 2,557.8%  
Shares outstanding (eoy) m42.061,761.50 2.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x5.77.2 79.0%   
Avg P/E ratio x35.241.1 85.7%  
P/CF ratio (eoy) x32.236.7 87.8%  
Price / Book Value ratio x7.19.8 72.3%  
Dividend payout %45.197.3 46.3%   
Avg Mkt Cap Rs m246,284557,603 44.2%   
No. of employees `0004.07.1 55.8%   
Total wages/salary Rs m5,2777,928 66.6%   
Avg. sales/employee Rs Th10,837.310,808.9 100.3%   
Avg. wages/employee Rs Th1,325.01,109.7 119.4%   
Avg. net profit/employee Rs Th1,757.71,900.5 92.5%   
INCOME DATA
Net Sales Rs m43,16577,219 55.9%  
Other income Rs m2,5743,052 84.3%   
Total revenues Rs m45,73980,270 57.0%   
Gross profit Rs m8,83416,177 54.6%  
Depreciation Rs m6441,622 39.7%   
Interest Rs m20531 3.8%   
Profit before tax Rs m10,74417,076 62.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-145 0.0%   
Tax Rs m3,7433,354 111.6%   
Profit after tax Rs m7,00113,577 51.6%  
Gross profit margin %20.520.9 97.7%  
Effective tax rate %34.819.6 177.4%   
Net profit margin %16.217.6 92.2%  
BALANCE SHEET DATA
Current assets Rs m45,62034,398 132.6%   
Current liabilities Rs m17,42624,344 71.6%   
Net working cap to sales %65.313.0 501.7%  
Current ratio x2.61.4 185.3%  
Inventory Days Days3559 58.3%  
Debtors Days Days2433 70.6%  
Net fixed assets Rs m5,13816,478 31.2%   
Share capital Rs m4211,762 23.9%   
"Free" reserves Rs m34,43155,304 62.3%   
Net worth Rs m34,85157,065 61.1%   
Long term debt Rs m03,643 0.0%   
Total assets Rs m54,12787,016 62.2%  
Interest coverage x530.233.2 1,597.6%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x0.80.9 89.9%   
Return on assets %13.016.2 80.0%  
Return on equity %20.123.8 84.4%  
Return on capital %30.928.8 107.4%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m3,0142,027 148.7%   
Fx outflow Rs m186804 23.1%   
Net fx Rs m2,8281,223 231.3%   
CASH FLOW
From Operations Rs m7,23010,890 66.4%  
From Investments Rs m-4,465-5,402 82.6%  
From Financial Activity Rs m-3,634-5,744 63.3%  
Net Cashflow Rs m-868-265 327.1%  

Share Holding

Indian Promoters % 0.0 68.6 -  
Foreign collaborators % 72.5 0.0 -  
Indian inst/Mut Fund % 0.8 5.6 14.3%  
FIIs % 12.0 19.2 62.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 14.8 6.5 227.7%  
Shareholders   26,457 123,555 21.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GSK CONSUMER With:   GOODRICKE  VADILAL INDUSTRIES  NESTLE  RASOYA PROTEINS  SANWARIA AGRO OILS  

Compare GSK CONSUMER With:   NESTLE (Switz.)  TIGER BRANDS (S. Africa)  COCA COLA (US)  AVI LTD. (S. Africa)  



Today's Market

Sensex Tanks ahead of Election Results; Realty Stocks Plummet(Closing)

Indian share markets settled around 2% lower today following a sell-off in the global markets and due to uncertainty over the outcome of state assembly elections tomorrow.

Related Views on News

DABUR Announces Quarterly Results (2QFY19); Net Profit Up 4.0% (Quarterly Result Update)

Nov 6, 2018 | Updated on Nov 6, 2018

For the quarter ended September 2018, DABUR has posted a net profit of Rs 4 bn (up 4.0% YoY). Sales on the other hand came in at Rs 21 bn (up 8.5% YoY). Read on for a complete analysis of DABUR's quarterly results.

GSK CONSUMER Announces Quarterly Results (2QFY19); Net Profit Up 43.2% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, GSK CONSUMER has posted a net profit of Rs 3 bn (up 43.2% YoY). Sales on the other hand came in at Rs 13 bn (up 14.0% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.

GSK CONSUMER Announces Quarterly Results (1QFY19); Net Profit Up 51.6% (Quarterly Result Update)

Aug 8, 2018 | Updated on Aug 8, 2018

For the quarter ended June 2018, GSK CONSUMER has posted a net profit of Rs 2 bn (up 51.6% YoY). Sales on the other hand came in at Rs 11 bn (up 5.9% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.

DABUR Announces Quarterly Results (1QFY19); Net Profit Up 24.7% (Quarterly Result Update)

Aug 1, 2018 | Updated on Aug 1, 2018

For the quarter ended June 2018, DABUR has posted a net profit of Rs 3 bn (up 24.7% YoY). Sales on the other hand came in at Rs 21 bn (up 16.2% YoY). Read on for a complete analysis of DABUR's quarterly results.

GSK CONSUMER Announces Quarterly Results (4QFY18); Net Profit Up 20.4% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, GSK CONSUMER has posted a net profit of Rs 2 bn (up 20.4% YoY). Sales on the other hand came in at Rs 12 bn (down 2.4% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.

More Views on News

Most Popular

My Top 7 Stocks to Buy Now(The 5 Minute Wrapup)

Nov 30, 2018

Of all the stocks that you could buy in this market, I've picked the seven best safe stocks that offer the ideal combination of safety and profit.

4 Rebound Stocks to Profit from the Current Small Cap Crash(Profit Hunter)

Dec 3, 2018

Indian small cap space is offering a discount season. Make sure you do not get too late to scoop up the bargains.

Reliance CPSE ETF (FFO3): Should You Invest?(Outside View)

Nov 29, 2018

Personalfn's analysis note on Reliance Mutual Fund Central Public Sector Enterprises Exchange Traded Fund (CPSE ETF). Should you subscribe?

Safety Beats Growth in 2018(Chart Of The Day)

Nov 30, 2018

With the markets turning up, these are my top 7 stock picks.

Looking For Higher Interest Rates on Bank FDs? Read This!(Outside View)

Dec 5, 2018

Credit disbursement to the productive sectors of the economy such as infrastructure, engineering, food processing, textiles, and chemicals, among others is rising.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

GSK CONSUMER SHARE PRICE


Dec 10, 2018 (Close)

TRACK GSK CONSUMER

  • Track your investment in GSK CONSUMER with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

GSK CONSUMER 8-QTR ANALYSIS

COMPARE GSK CONSUMER WITH

MARKET STATS